advertisement

Topcon

Frontiers in pharmacology 11

Showing records 1 to 11 | Display all abstracts in Frontiers in pharmacology

100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Lambuk L
Frontiers in pharmacology 2022; 13: 875662
100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Li G
Frontiers in pharmacology 2022; 13: 919688
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Mohd Lazaldin MA
Frontiers in pharmacology 2022; 13: 875662
100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Wang N
Frontiers in pharmacology 2022; 13: 919688
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Ahmad S
Frontiers in pharmacology 2022; 13: 875662
100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Zhang Y; Wei W
Frontiers in pharmacology 2022; 13: 919688
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Iezhitsa I; Agarwal R
Frontiers in pharmacology 2022; 13: 875662
100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Lu H; Zhai S
Frontiers in pharmacology 2022; 13: 919688
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Uskoković V; Mohamud R
Frontiers in pharmacology 2022; 13: 875662
100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Zhang C
Frontiers in pharmacology 2022; 13: 919688
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Mohamud R
Frontiers in pharmacology 2022; 13: 875662

Issue 23-1

Change Issue


advertisement

Nidek